Skip to content
Research Article Open access CC BY 4.0

The Emerging Focus on Pharmacogenomics

Charles Edeki

International Journal of Biochemistry Research & Review · pp. 1–6 · Published 29 Aug 2019

10.9734/ijbcrr/2019/v27i230114

Abstract

Drugs are designed to treat medical conditions for the general population. Idiosyncratic reactions to drugs are determined by the individual’s respective genetic variations that direct effectiveness and side effects. Adverse drug reactions rank within the top ten leading causes of death in the developed world. The field of pharmacogenomics has advanced in the last fifty years, picking up significant momentum with recent biotechnological developments that allow scientists to investigate the human genome and provide individualized drug therapy that will increase the efficacy of drugs and decrease the incidence of adverse drug reactions. Pharmacogenomics has reached a milestone in making personalized medicine accessible and effective. The medical community shares this responsibility for the emerging focus on pharmacogenomics with regulatory agencies and bioinformatics specialists as they struggle to streamline vast libraries of information and reconcile public and regulatory approval on this critical path to the next level of health care.

Pharmacogenomics bioinformatics Alleviate Adverse Drug Reactions (ADRs) biochips.

References (7)

  1. 1 From Human Genetics and Genomics to Pharmacogenetics and Pharmacogenomics: Past Lessons, Future Directions [DOI]
  2. 2 Overcoming regulatory and economic challenges facing pharmacogenomics [DOI]
  3. 3 Pharmacogenomics in neurology: Current state and future steps [DOI]
  4. 4 Pharmacogenetics in the treatment of breast cancer [DOI]
  5. 5 Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy [DOI]
  6. 6 Pharmacogenomic approaches in the treatment of breast cancer by tamoxifen.
  7. 7 Pharmacogenomics and its implications for autoimmune disease [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

8

Page views

0

PDF downloads

8

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.